Insiders · LRMR

LRMR insider transactions

Larimar Therapeutics Inc. (LRMR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LRMR

• 59d
  * Director by Deputization Flynn James E bought $25,000,000 worth of shares (5,000,000 units at $5.00) (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 59d
  Director Hamilton Thomas Edward bought $500,000 worth of shares (100,000 units at $5.00), increasing direct ownership by 18% to 664,798 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 59d
  Director Thomas Frank E bought $25,000 worth of shares (5,000 units at $5.00), increasing direct ownership by 250% to 7,000 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 59d
  Director Sherman Jeffrey W bought $25,000 worth of shares (5,000 units at $5.00) (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  Chief Development Officer Shankar Gopi was granted 25,637 shares, increasing direct ownership by 50% to 76,443 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  Chief Medical Officer Clayton Russell was granted 25,637 shares, increasing direct ownership by 56% to 71,443 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  President and CEO Ben-Maimon Carole was granted 100,100 shares, increasing direct ownership by 37% to 368,276 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 93d
  Chief Financial Officer Celano Michael was granted 37,604 shares, increasing direct ownership by 21% to 215,785 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 269d
  * Director by Deputization Flynn James E bought $30,000,000 worth of shares (9,375,000 units at $3.20) (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 350d
  SEC Form 4 filed by * Director by Deputization Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Sherman Jeffrey W

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Hamilton Thomas Edward

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 351d
  SEC Form 4 filed by Director Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  Chief Development Officer Shankar Gopi was granted 23,306 shares, increasing direct ownership by 85% to 50,806 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  Chief Medical Officer Clayton Russell was granted 23,306 shares, increasing direct ownership by 104% to 45,806 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  President and CEO Ben-Maimon Carole was granted 91,000 shares, increasing direct ownership by 31% to 387,208 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 461d
  Chief Financial Officer Celano Michael was granted 34,185 shares, increasing direct ownership by 24% to 178,181 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 696d
  SEC Form 4 filed by Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Sherman Jeffrey W

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 699d
  Hamilton Thomas Edward bought $499,998 worth of shares (57,208 units at $8.74), increasing direct ownership by 11% to 564,798 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 804d
  Flynn James E bought $37,499,993 worth of shares (4,290,617 units at $8.74) (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 805d
  Thomas Frank E bought $22,000 worth of shares (2,000 units at $11.00) (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Shankar Gopi was granted 22,500 shares, increasing direct ownership by 450% to 27,500 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Celano Michael was granted 31,250 shares, increasing direct ownership by 28% to 143,996 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Clayton Russell was granted 22,500 shares (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 832d
  Ben-Maimon Carole was granted 66,125 shares, increasing direct ownership by 25% to 332,954 units (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 874d
  Shankar Gopi bought $18,662 worth of shares (5,000 units at $3.73) (SEC Form 4)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 938d
  SEC Form 4 filed by Sherman Jeffrey W

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 938d
  SEC Form 3 filed by new insider Sherman Jeffrey W

  3 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1017d
  SEC Form 4 filed by Clayton Russell

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1017d
  SEC Form 3 filed by new insider Clayton Russell

  3 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1078d
  SEC Form 4 filed by Celano Michael

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1078d
  SEC Form 4 filed by Ben-Maimon Carole

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1078d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Flynn James E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Hamilton Thomas Edward

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1085d
  SEC Form 4 filed by Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1176d
  SEC Form 4 filed by Shankar Gopi

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1176d
  SEC Form 3 filed by new insider Shankar Gopi

  3 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1183d
  SEC Form 4: Celano Michael was granted 76,000 shares, increasing direct ownership by 239% to 107,746 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1183d
  SEC Form 4: Ben-Maimon Carole was granted 205,000 shares, increasing direct ownership by 361% to 261,829 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1318d
  SEC Form 4: Flynn James E bought $34,999,990 worth of shares (11,111,108 units at $3.15)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1318d
  SEC Form 3: New insider Deerfield Partners, L.P. claimed ownership of 2,777,777 shares

  3 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1318d
  SEC Form 4: Hamilton Thomas Edward bought $999,999 worth of shares (317,460 units at $3.15), increasing direct ownership by 167% to 507,590 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1319d
  SEC Form 4: Celano Michael bought $100,000 worth of shares (31,746 units at $3.15)

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1319d
  SEC Form 4: Ben-Maimon Carole bought $100,000 worth of shares (31,746 units at $3.15), increasing direct ownership by 127% to 56,829 units

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Ben-Maimon Carole

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Celano Michael

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Truitt Joseph

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Barrett Peter

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Hamilton Thomas Edward

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Thomas Frank E

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)
• 1449d
  SEC Form 4 filed by Leff Jonathan S

  4 - Larimar Therapeutics, Inc. (0001374690) (Issuer)